MITSUBISHI TANABE PHARMA CORPORATION : Announces Results of the MT-7117 ENDEAVOR Study for the Ultra-Rare Disease, Erythropoietic Protoporphyria

Press/Media

Period12 Nov 2019

Media coverage

2

Media coverage